NCT00160862View on ClinicalTrials.gov

NK-1 Antagonism of SLV317 in Humans

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

SLV317

Trial Locations (1)

69120

Dept. of Internal Medicine VI, University of Heidelberg, Heidelberg

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT00160862 - NK-1 Antagonism of SLV317 in Humans | Biotech Hunter | Biotech Hunter